Shruti Gandhi: The reason we don’t talk about our fund size is because of LP issues. We are a smaller fund. Those smaller exits are great for us in terms of returning the capital. Oftentimes when you start a company and you’re thinking about a $15 million exit, that could be your ceiling in some
Sramana Mitra: Let’s talk a little bit about how you built the pieces of the business. Let’s talk about the retail e-commerce piece. It sounds like there is inventory involved. Did you finance the inventory through some bank, or did you just do it organically? Sina Khanifar: That’s where seed capital came in. We didn’t
In case you missed it, you can listen to the recording here: Rendezvous Online with Sramana Mitra 1.28.20
Sramana Mitra: You don’t need them to finish the product? Shruti Gandhi: No. One of our companies barely had a deck. Sramana Mitra: You want customer validation from their network. Then you want to take that concept and shop it around in your relevant network. If all that checks out, you’re okay with writing a
Entrepreneurs are invited to the 480th FREE online 1Mby1M mentoring roundtable on Thursday, April 9, 2020, at 8 a.m. PDT/11 a.m. EDT/5 p.m. CEST/8:30 p.m. India IST. If you are a serious entrepreneur, register to “pitch” and sell your business idea. You’ll receive straightforward feedback, advice on next steps, and answers to any of your
Sramana Mitra: What was Waveform going to do in 2006? Sina Khanifar: We graduated college and were trying to figure out which up and coming industry we could get started in. My dad had just come back from South Korea. He mentioned that in South Korea, all the buildings had device repeaters that would help
Responding to a popular request, we are now sharing transcripts of our investor podcast interviews in this new series. The following interview with Shruti Gandhi was recorded in March 2020. Shruti Gandhi is General Partner and Founding Engineer, Array Ventures, a fund focused on deep tech, enterprise-facing ventures.
Darshana Zaveri, Managing Partner at Catalyst Health Ventures, discusses the firm’s medical device focused investment thesis, including the nuances of epidemiologic diagnostic that are currently immensely relevant. The Catalyst investment team also includes Managing Partner Josh Phillips and Principal Neil Swami.